FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biochemistry, in particular to donor DNA for the delivery of a protective peptide from gp41 MT-C34. Methods for delivery of a protective peptide from gp41 MT-C34 are also disclosed.
EFFECT: invention makes it possible to effectively edit the CXCR4 gene in CD4 lymphocytes.
3 cl, 4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING A LINE OF HUMANIZED MICE CONTAINING 3974insT INSERTION IN THE mGrin2a GENE (MICE GLUTAMATE [NMDA] RECEPTOR SUBUNIT EPSILON-1), LEADING TO PREMATURE TERMINATION OF TRANSLATION OF THE grin2a PROTEIN | 2021 |
|
RU2764650C1 |
| TECHNOLOGY FOR CREATING T-CELL RESISTANCE TO HIV-1 BASED ON GENETICALLY ENCODED GPI-ANCHORED PEPTIDES FROM GP41 | 2020 |
|
RU2769567C1 |
| HERPES VACCINE | 2019 |
|
RU2731073C1 |
| ARTIFICIAL GENES CODING EV.CTL AND EV.Th PROTEINS-IMMUNOGENS, RECOMBINANT PLASMID DNA pEV.CTL AND EV.Th, PROVIDING EXPRESSION OF ARTIFICIAL GENES, AND ARTIFICIAL T-CELL POLYEPITOPE PROTEINS-IMMUNOGENS EV.CTL AND EV.Th CONTAINING EPITOPES OF EBOLA VIRUS ANTIGENS, USED TO CREATE AN EBOLA VIRUS VACCINE | 2018 |
|
RU2713723C1 |
| UNIVERSAL ANTIBODY-MEDIATED BIOSENSOR | 2016 |
|
RU2746486C2 |
| IMMUNO-INDUCING AGENT | 2016 |
|
RU2744843C2 |
| METHOD FOR OBTAINING A LINE OF HUMANISED MICE, TRANSGENIC BY hACE2 | 2020 |
|
RU2757114C1 |
| MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
| GENETIC CONSTRUCT ADAPTED TO DELIVER THE HUMAN SMN1 GENE WITH ADENO-ASSOCIATED VIRUS OF SEROTYPE 2 TO PROVIDE NEUROSPECIFIC EXPRESSION | 2022 |
|
RU2801848C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT TUMOUR | 2016 |
|
RU2714205C2 |
